1192.1 - The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques (resubmission)

Page last updated: 11 July 2016

Application Detail

Status

Closed

Description of Medical Service

Percutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/transeptal techniques is performed while the heart is beating, which better allows the identification of the origin of mitral regurgitation (MR).

Description of Medical Condition

MR occurs when the leaflets (or flaps) of the heart’s mitral value do not close properly and leak. The mitral valve is a one-way valve that separates the left atrium (a chamber in the heart which collects blood from the lungs) from the left ventricle (a chamber in the heart which pumps blood to the rest of the body). During pumping, the leak in the mitral valve causes blood to flow backwards into the left atrium, thereby decreasing blood flow to the body. To maintain blood flow to the body and compensate for the MR, the left ventricle must pump harder. Back flow due to MR places an extra burden on the left ventricle and lungs. Eventually, this burden can cause other problems such as: stroke, sudden death, irregular heartbeat, increasing damage to the heart muscle (progressive myocardial injury); and/or the inability to maintain adequate circulation of blood (congestive heart failure).

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number

1192

Associated Documentation

Application Form

-

PICO Confirmation

Please see the Final Protocol for MSAC Application 1192

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 165 KB)
Public Summary Document (Word 95 KB)

Meetings for this Application

PASC

-

ESC

13-14 February 2014

MSAC

3-4 April 2014